Immune Checkpoint Drugs in Oncology: Analytical Tool – A Must-Have Handbook for Business Developers, BI/CI Operatives, and Clinical Developers
April 25, 2024 10:26 ET
|
Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Immune-checkpoint Drugs in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com's offering.Cancer cells sometimes find ways to...
Global Gallbladder Cancer Clinical Trials Review 2023: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status
January 31, 2024 06:46 ET
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Gallbladder Cancer - Global Clinical Trials Review, 2023" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial...
Apoptosis Assays Market Sees Robust Growth, Driven by Advances in Biomedical Research and Drug Development
January 05, 2024 03:58 ET
|
Research and Markets
Dublin, Jan. 05, 2024 (GLOBE NEWSWIRE) -- The "Apoptosis Assays Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been added to ResearchAndMarkets.com's...
Pediatric Clinical Trials Market Forecasted Growth with New Innovations and Global Reach in 2023
December 20, 2023 10:08 ET
|
Research and Markets
Dublin, Dec. 20, 2023 (GLOBE NEWSWIRE) -- The "Pediatric Clinical Trials Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The pediatric clinical trials...
DNA Damage Response (DDR) Drugs in Oncology Analytical Tool 2022: The Must have Handbook for Any Business Developer, BI/CI Operative or Clinical Developer
July 26, 2022 04:43 ET
|
Research and Markets
Dublin, July 26, 2022 (GLOBE NEWSWIRE) -- The "DNA Damage Response (DDR) Drugs in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com's offering. DNA Damage Response (DDR)...
World Immune-checkpoint Drugs in Oncology Analytical Handbook 2022
June 08, 2022 03:18 ET
|
Research and Markets
Dublin, June 08, 2022 (GLOBE NEWSWIRE) -- The "Immune-checkpoint Drugs in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com's offering. Immune-checkpoint Drugs in Oncology:...
2022 Oncolytic Virotherapies Analytical Tool: 85 Companies Who are Developing 150 Oncolytic Virus Drugs Where 113 are in Active Development in Cancer Across 40 Different Targets
May 11, 2022 07:03 ET
|
Research and Markets
Dublin, May 11, 2022 (GLOBE NEWSWIRE) -- The "Oncolytic Virotherapies: Analytical Tool" report has been added to ResearchAndMarkets.com's offering.Oncolytic Virotherapies: Analytical Tool is the...